59 results
8-K
EX-1.1
FATE
Fate Therapeutics Inc
20 Mar 24
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
5:32pm
of the environment or human exposure to hazardous or toxic substances (collectively, “Environmental Laws”), owns or operates any real property contaminated
424B5
FATE
Fate Therapeutics Inc
20 Mar 24
Prospectus supplement for primary offering
5:30pm
efforts, technological advances and the competitive environment for our product candidates. As of the date of this prospectus supplement, we cannot … of any partnering efforts, technological advances and the competitive environment for our product candidates. As of the date of this prospectus, we
8-K
EX-1.1
utevh8x0mgq1ijku
4 Nov 21
Entry into a Material Definitive Agreement
4:59pm
S-3ASR
sxhe6mh4enst2
4 Nov 21
Automatic shelf registration
4:56pm
S-3ASR
EX-1.2
3oewy8yviwi 4nleqhh5
4 Nov 21
Automatic shelf registration
4:56pm